SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
India has a pivotal role in eliminating TB
Integration of modern and traditional medicine to facilitate the illness to wellness journey
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Expands robotics to 20+ specialities
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Proposed combination enhances Pfizer’s position as a leading company in oncology
Time to combine innovation, access and technology to deliver positive patient outcomes
Subscribe To Our Newsletter & Stay Updated
